PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders

E-ISSN： 1875-5704|14|6|791-796

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.14, Iss.6, 2017-09, pp. : 791-796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 148-157

Bentham Science Publishers

Access to resources Recommend Favorite

The Central Sympathetic Nervous System: A New Target for Cardioprotective Drugs

Drug Design Reviews - Online, Vol. 2, Iss. 4, 2005-06 ,pp. : 259-266

Bentham Science Publishers

Access to resources Recommend Favorite

The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-01 ,pp. : 303-313

Bentham Science Publishers

Access to resources Recommend Favorite